Type 2 diabetes Nutritional, Metabolic, Endocrine
Conditions
Interventions
This single-arm feasibility trial is to evaluate a 12-week revised WWDP for midlife women (45 to 65 years) in the UK. A mixed-methods design will be applied to fulfil the evaluation aims. There will b
Sponsors
King's College London
Eligibility
Sex/Gender
Female
Age
45 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Women aged =45 and =65 years 2. A current diagnosis of T2DM 3. Using medication to treat T2DM (insulin or oral medication) 4. Living in the UK and with access to diabetes care in the NHS 5. Able to read and speak English 6. Access to a computer or laptop, reliable internet access and IT literacy (defined as being able to buy a product over the internet, search for a topic and send an email) 7. Not currently participating in other research 8. Have a Facebook account or accepts to open a new Facebook account 9. Receive all diabetes care through GP surgery 10. Diabetes distress score 2 or above on the DDS scale
Exclusion criteria
Exclusion criteria: 1. Women diagnosed with type 1 diabetes or GDM 2. Unable to read and understand English 3. Women without computer or internet access 4. Women who currently participate in other research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility outcome measures: 1. Recruitment rate via the social media campaign, calculated as the percentage of eligible participants who enrolled in the study 2. Intervention/peer group attendance, calculated as the proportion of participants who logged into the online peer group site on at least three occasions over the 12 weeks 3. Data quality, calculated as the proportion of participants who provided data at all three timepoints | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Distress measured using the Diabetes Distress Scale at baseline (within 7 days), 3 months and 6 months post baseline 2. Confidence in self-management using the Diabetes Management Self-Efficacy Scale (DMSES UK) at baseline (within 7 days), 3 months and 6 months post baseline 3. Quality of life measured using the Short-Form health survey (SF-36) at baseline (within 7 days), 3 months and 6 months post baseline 4. Physical activity measured using the International Physical Activity Questionnaire (IPAQ) at baseline (within 7 days), 3 months and 6 months post baseline 5. Dietary behaviours on diabetes management assessed using the UK version Diabetes and Diet Questionnaire (UKDDQ) at baseline (within 7 days), 3 months and 6 months post baseline 6. Smoking prevalence assessed using a subset of key questions from the Global Adult Tobacco Survey at baseline (within 7 days), 3 months and 6 months post baseline 7. Sleep activity and quality assessed using the 21-item General Sleep Disturbance Scale at baseline (within 7 days), 3 months and 6 months post baseline 8. Menopausal symptoms assessed using the standard Greene Climacteric Scale at baseline (within 7 days), 3 months and 6 months post baseline 9. The Goal Assessment Scale (GAS) was used to assess whether participants had achieved their goals within 7 days of receiving the form in week 12 using a +2 to -2 scale 10. Physiological measures: anthropometric measures including body weight, height, waist and hip circumferences and body mass index (BMI) at at baseline (within 7 days), 3 months and 6 months post baseline | — |
Countries
England, United Kingdom
Contacts
Public ContactDeniz Bozkurt
Outcome results
None listed